NIH Small Business Innovation Research (SBIR) Phase IIB Strategic Breakthrough Award (Parent [R44] Clinical Trial Optional)
This open federal grant from National Institutes of Health supports health-focused work and is available to eligible applicants, with applications due Apr 5, 2029.
See full details on Grants.govOpportunity description
Who can apply
- Small businesses
Only United States small business concerns (SBCs) that have previously received an NIH SBIR or STTR Phase II award are eligible to submit applications for this opportunity. Only one NIH Phase IIB Strategic Breakthrough award is allowed per project. This NOFO supports Renewal/Resubmission "Type 2" Applications from recipients with NIH Phase II SBIR/STTR awards that are submitted within the first six due dates following the expiration of their budget period. Refer to Section III. Eligibility Information in the NOFO for additional information on eligibility.Foreign Organizations/International Collaborations:Non-domestic (non-U.S.) Entities (Foreign Organizations) are not eligible to apply.Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.Unfunded international collaborations or unfunded foreign components, as defined in the NIH Grants Policy Statement, may be allowed.
Agency contact
National Institutes of Health
NIH SEED (Small business Education and Entrepreneurial Development) SEEDinfo@nih.gov
SEEDinfo@nih.govWhere to apply
Submission is handled entirely on Grants.gov. Open the official listing below to see the full notice, required forms, and the authoritative deadline.
Official Grants.gov listingInformation here comes from the public Grants.gov dataset, which is U.S. government public-domain data, and is shared for general guidance only. VolunteerBadge neither administers grants nor speaks for any agency — confirm everything on the official listing before applying.